These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 30335012

  • 1. Effect of white-coat hypertension on arterial stiffness: A meta-analysis.
    Cai P, Peng Y, Wang Y, Wang X.
    Medicine (Baltimore); 2018 Oct; 97(42):e12888. PubMed ID: 30335012
    [Abstract] [Full Text] [Related]

  • 2. Central pressures and central hemodynamic values in white coat hypertensives are closer to those of normotensives than to those of controlled hypertensives for similar age, gender, and 24-h and nocturnal blood pressures.
    Almeida J, Monteiro J, Silva JA, Bertoquini S, Polónia J.
    Rev Port Cardiol; 2016 Nov; 35(11):559-567. PubMed ID: 27717519
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension.
    Aznaouridis K, Vlachopoulos C, Masoura K, Pietri P, Vyssoulis G, Ioakeimidis N, Stefanadis C, Tousoulis D.
    Int J Cardiol; 2016 Jan 15; 203():98-103. PubMed ID: 26498870
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. White coat hypertension is more risky than prehypertension: important role of arterial wave reflections.
    Sung SH, Cheng HM, Wang KL, Yu WC, Chuang SY, Ting CT, Lakatta EG, Yin FC, Chou P, Chen CH.
    Hypertension; 2013 Jun 15; 61(6):1346-53. PubMed ID: 23608649
    [Abstract] [Full Text] [Related]

  • 9. Arterial stiffness in children and adolescents with masked and sustained hypertension.
    Kollios K, Nika T, Kotsis V, Chrysaidou K, Antza C, Stabouli S.
    J Hum Hypertens; 2021 Jan 15; 35(1):85-93. PubMed ID: 32099080
    [Abstract] [Full Text] [Related]

  • 10. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
    Wojciechowska W, Stolarz-Skrzypek K, Olszanecka A, Klima Ł, Gąsowski J, Grodzicki T, Kawecka-Jaszcz K, Czarnecka D.
    Blood Press; 2016 Aug 15; 25(4):249-56. PubMed ID: 26953075
    [Abstract] [Full Text] [Related]

  • 11. White coat hypertension is another clinical characteristic of patients with inflammatory bowel disease: A cross-sectional study.
    Premužić V, Prijić R, Jelaković M, Krznarić Ž, Čuković-Čavka S, Jelaković B.
    Medicine (Baltimore); 2022 Nov 04; 101(44):e29722. PubMed ID: 36343048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relations between white coat effects and left ventricular mass index or arterial stiffness: role of nocturnal blood pressure dipping.
    Maseko MJ, Woodiwiss AJ, Libhaber CD, Brooksbank R, Majane OH, Norton GR.
    Am J Hypertens; 2013 Nov 04; 26(11):1287-94. PubMed ID: 23926123
    [Abstract] [Full Text] [Related]

  • 14. Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population.
    Johansson MAK, Östgren CJ, Engvall J, Swahn E, Wijkman M, Nystrom FH.
    J Hypertens; 2021 Oct 01; 39(10):2009-2014. PubMed ID: 33973957
    [Abstract] [Full Text] [Related]

  • 15. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
    Silva JA, Barbosa L, Bertoquini S, Maldonado J, Polónia J.
    Rev Port Cardiol; 2004 Dec 01; 23(12):1533-47. PubMed ID: 15732656
    [Abstract] [Full Text] [Related]

  • 16. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
    Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, Kaplan N, Victor R, Vongpatanasin W.
    J Am Coll Cardiol; 2015 Nov 17; 66(20):2159-2169. PubMed ID: 26564592
    [Abstract] [Full Text] [Related]

  • 17. Correlates of aortic stiffness progression in patients with resistant hypertension: importance of clinic and ambulatory blood pressure changes.
    Roderjan CN, Cardoso CR, Ferreira MT, Muxfeldt ES, Salles GF.
    J Hypertens; 2015 Apr 17; 33(4):827-34; discussion 834-5. PubMed ID: 25915888
    [Abstract] [Full Text] [Related]

  • 18. Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.
    Androulakis E, Papageorgiou N, Lioudaki E, Chatzistamatiou E, Zacharia E, Kallikazaros I, Tousoulis D.
    J Clin Hypertens (Greenwich); 2017 Feb 17; 19(2):190-197. PubMed ID: 27440165
    [Abstract] [Full Text] [Related]

  • 19. Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis.
    Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G.
    Blood Press Monit; 2015 Apr 17; 20(2):57-63. PubMed ID: 25405819
    [Abstract] [Full Text] [Related]

  • 20. Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension.
    Yavuzer H, Cengiz M, Yavuzer S, Rıza Altıparmak M, Korkmazer B, Balci H, Yaldıran AL, Uzun H.
    J Hum Hypertens; 2016 Jul 17; 30(7):424-9. PubMed ID: 26040439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.